136 related articles for article (PubMed ID: 9062488)
1. Aspirin inhibits vasopressin-induced hypothalamic-pituitary-adrenal activity in normal humans.
Nye EJ; Hockings GI; Grice JE; Torpy DJ; Walters MM; Crosbie GV; Wagenaar M; Cooper M; Jackson RV
J Clin Endocrinol Metab; 1997 Mar; 82(3):812-7. PubMed ID: 9062488
[TBL] [Abstract][Full Text] [Related]
2. Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.
Hockings GI; Grice JE; Crosbie GV; Walters MM; Jackson AJ; Jackson RV
J Clin Endocrinol Metab; 1993 Aug; 77(2):404-8. PubMed ID: 8393884
[TBL] [Abstract][Full Text] [Related]
3. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
[TBL] [Abstract][Full Text] [Related]
4. Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity.
Vicennati V; Ceroni L; Gagliardi L; Pagotto U; Gambineri A; Genghini S; Pasquali R
J Endocrinol Invest; 2004 Jun; 27(6):541-7. PubMed ID: 15717651
[TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans.
Arvat E; Maccagno B; Giordano R; Pellegrino M; Broglio F; Gianotti L; Maccario M; Camanni F; Ghigo E
J Clin Endocrinol Metab; 2001 Jul; 86(7):3176-81. PubMed ID: 11443185
[TBL] [Abstract][Full Text] [Related]
6. Hypothalamo-pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration: sex differences between major depressives and matched control subjects.
Rubin RT; O'Toole SM; Rhodes ME; Sekula LK; Czambel RK
Psychiatry Res; 1999 Dec; 89(1):1-20. PubMed ID: 10643873
[TBL] [Abstract][Full Text] [Related]
7. Evidence of basal pituitary-adrenal overactivity in first episode, drug naïve patients with schizophrenia.
Ryan MC; Sharifi N; Condren R; Thakore JH
Psychoneuroendocrinology; 2004 Sep; 29(8):1065-70. PubMed ID: 15219658
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion.
Mastorakos G; Weber JS; Magiakou MA; Gunn H; Chrousos GP
J Clin Endocrinol Metab; 1994 Oct; 79(4):934-9. PubMed ID: 7962300
[TBL] [Abstract][Full Text] [Related]
9. Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans.
Grottoli S; Maccagno B; Ramunni J; Di Vito L; Giordano R; Gianotti L; DeStefanis S; Camanni F; Ghigo E; Arvat E
J Endocrinol Invest; 2002 May; 25(5):420-5. PubMed ID: 12035937
[TBL] [Abstract][Full Text] [Related]
10. Glutamate agonists activate the hypothalamic-pituitary-adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg neurons.
Zelena D; Mergl Z; Makara GB
Brain Res; 2005 Jan; 1031(2):185-93. PubMed ID: 15649443
[TBL] [Abstract][Full Text] [Related]
11. Effects of different treatments for hyperthyroidism on the hypothalamic-pituitary-adrenal axis.
Lizcano F; Salvador J
Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1085-90. PubMed ID: 18505442
[TBL] [Abstract][Full Text] [Related]
12. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis.
Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779
[TBL] [Abstract][Full Text] [Related]
13. Influence of nitric oxide synthase inhibitors on the vasopressin-induced pituitary-adrenocortical activity and hypothalamic catecholamine levels.
Bugajski J; Gadek-Michalska A; Głód R; Borycz J
J Physiol Pharmacol; 1998 Dec; 49(4):617-26. PubMed ID: 10069702
[TBL] [Abstract][Full Text] [Related]
14. Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans.
Arvat E; Maccagno B; Ramunni J; Maccario M; Giordano R; Broglio F; Camanni F; Ghigo E
Eur J Endocrinol; 2000 Jul; 143(1):99-104. PubMed ID: 10870037
[TBL] [Abstract][Full Text] [Related]
15. Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests.
Nye EJ; Grice JE; Hockings GI; Strakosch CR; Crosbie GV; Walters MM; Jackson RV
J Clin Endocrinol Metab; 1999 Oct; 84(10):3648-55. PubMed ID: 10523009
[TBL] [Abstract][Full Text] [Related]
16. Effect of cyclooxygenase inhibitors on the vasopressin induced ACTH and corticosterone response during crowding stress.
Bugajski J; Gadek-Michalska A
J Physiol Pharmacol; 2003 Jun; 54(2):247-56. PubMed ID: 12832725
[TBL] [Abstract][Full Text] [Related]
17. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW
Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883
[TBL] [Abstract][Full Text] [Related]
18. The acute effects of oral ethanol on the hypothalamic-pituitary-adrenal axis in normal human subjects.
Inder WJ; Joyce PR; Wells JE; Evans MJ; Ellis MJ; Mattioli L; Donald RA
Clin Endocrinol (Oxf); 1995 Jan; 42(1):65-71. PubMed ID: 7889634
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats.
Gil-Lozano M; Romaní-Pérez M; Outeiriño-Iglesias V; Vigo E; González-Matías LC; Brubaker PL; Mallo F
Endocrinology; 2014 Jul; 155(7):2511-23. PubMed ID: 24731096
[TBL] [Abstract][Full Text] [Related]
20. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway.
Kakui N; Kitamura K
Endocrinology; 2007 Jun; 148(6):2854-62. PubMed ID: 17363455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
